PITTSBURGH — Colin Mackenzie has been appointed the new president of GlaxoSmithKline Consumer Healthcare North America. Mackenzie succeeds Roger Scarlett-Smith, who is relocating to London to become president of GSK Consumer Healthcare Europe.
Mackenzie has been directing the U.S. oral care business since 2007. Under the leadership of MacKenzie, the business accelerated its net sales growth rate, acquired the leading dry mouth product, Biotene, in 2008, and claimed the No. 1 toothpaste SKU in the United States (Sensodyne Extra Whitening).
Prior to leading the oral care business, Mackenzie was VP and general manager of the Central and Eastern Europe division. Under his leadership, the region became the fourth-largest operating unit and second-largest over-the-counter business for GSK Consumer Healthcare in Europe. He also held global positions as VP Aquafresh Future Team and VP strategic advertising and marketing leadership while based in the United Kingdom.
"Colin has demonstrated knowledge of the business and a commitment to implementing new, innovative ways to drive growth," stated John Clarke, president of GlaxoSmithKline Consumer Healthcare. "His transformation of the oral care business in North America is just one example of his ability to lead, inspire and empower, and I'm looking forward to the impact he will make in this new challenging role."
Roger Scarlett-Smith began his role as president of Consumer Healthcare North America in 2008. Prior to moving to Pittsburgh, Scarlett-Smith spent four years leading GSK's Consumer Healthcare business in the United Kingdom.